# Testing Pembrolizumab Versus Observation in Patients With Merkel Cell Carcinoma After Surgery, STAMP Trial

> clinical trial · VERIFIED · 2026-07-31

Status: ACTIVE_NOT_RECRUITING · Sponsor: National Cancer Institute (NCI) · Condition: Pathologic Stage I Cutaneous Merkel Cell Carcinoma AJCC v8

- Company: National Cancer Institute (NCI)
- Sector: Pathologic Stage I Cutaneous Merkel Cell Carcinoma AJCC v8
- Primary source: https://clinicaltrials.gov/study/NCT03712605

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.